Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JackieBadger
    Senior Member
    • Mar 2009
    • 385

    How does nanopore allow targeted sequencing of large genomic regions?

    An advantage boasted by oxford nanopore is that no PCR is required. However, it is not clear to me how one would target a large genomic region, say 1MB for arguments sake, without a huge PCR at a low number of cycles?

    Thinking "nanopore" is new to me so please excuse me if the answer to my questions is elementary.

    Cheers,

    J
  • singlemoleculer
    Junior Member
    • Jan 2012
    • 8

    #2
    One advantage to nanodetector technologies like Oxford and Nabsys is that they are single molecule so you look at individual molecules rather than large pools of identical molecules. Typically, you would not target a specific region but would look at the entire sample that would include the whole genome. I am not aware of any methods for efficiently targeting very long DNAs (other than flow sorting chromosomes or the like). If throughput is high enough, that is not a problem. If throughput is low, it is a problem.

    Comment

    • JackieBadger
      Senior Member
      • Mar 2009
      • 385

      #3
      This is what I thought.
      So it essentially relies on being able to sequence an entire genome, or chromosome, that contains your region of interest.

      What is the maximum sequence achieved thus far using nanopore seq?
      Last I heard it was ~48KB

      Comment

      • singlemoleculer
        Junior Member
        • Jan 2012
        • 8

        #4
        I think you are referring to the Oxford data that was discussed but not really shown at AGBT12. At AGBT14, more detail was given though still limited. Average read length in the data described by Jaffe was 5 kb with the long tail up to about 10 kb. Nabsys uses a mapping rather than sequencing approach so it is used in a complementary fashion with short reads. Base-by-base data from short reads is combined with long range information from single-molecule nanodetector traces. Nabsys showed molecules up to 150kb in length. Posters of this are online: http://www.nabsys.com/News-Events/Pu...entations.aspx

        Comment

        • JackieBadger
          Senior Member
          • Mar 2009
          • 385

          #5
          thanks!

          j

          Comment

          • seqsense
            Junior Member
            • Feb 2014
            • 5

            #6
            Hey, don't forget that unless the sequencing is done on a single cell, which does happen for researching tumour genesis, there will be many, many copies of the DNA already without the need for PCR given the multiple cells that will be extracted in sample preparation.

            Besides, there's been comment about the nature of the T issue being a systematic problem that bioinformaticians can't handle well, but PCR always introduces systematic errors by its very nature and also drowns out any hope of identifying any other bases except A, C, G and T.

            But now there are five different C's! What else don't we know.

            Comment

            • JackieBadger
              Senior Member
              • Mar 2009
              • 385

              #7
              Originally posted by seqsense View Post

              Besides, there's been comment about the nature of the T issue being a systematic problem that bioinformaticians can't handle well, but PCR always introduces systematic errors by its very nature and also drowns out any hope of identifying any other bases except A, C, G and T.

              But now there are five different C's!
              I'm sorry but I don't follow any of this.

              What is "the T issue"?
              What evidence is there to support that there are more than five nitrogenous bases and how does PCR suppress this evidence?
              What are the "five different C's"

              Comment

              • singlemoleculer
                Junior Member
                • Jan 2012
                • 8

                #8
                I can't comment on the T issue. No clue either. As for more than 5 bases, there are hordes of different modified bases that vary with species. In humans 5meC is most common but that is not true for all species. The next most common in humans is probably 5hydroxymethylC. PCR obscures this because the history of modification is lost when the DNA is copied multiple times during PCR. Single-molecule systems like PacBio or Oxford can, in theory and sometimes in practice, detect some of these because the modified bases are detected or copied directly. As for multiple cells being used for sequencing, that does not eliminate the need for PCR with non-single-molecule systems because each molecule has to be identical but each cell's DNA will break in unique ways. PCR is needed to make the ends the same. And yes, this can and does introduce issues with amplification bias and sometimes copying errors.

                Comment

                • JackieBadger
                  Senior Member
                  • Mar 2009
                  • 385

                  #9
                  OK. It wasn't immediately clear that he was refrying to modification of bases by methylation. It will be interesting to see if we can harness this information in DNA sequencing down the road, and the implications that it may have.

                  Comment

                  • seqsense
                    Junior Member
                    • Feb 2014
                    • 5

                    #10
                    So far, apart from C, MeC and HOMeC, there's also evidence of 5-carboxy-C and 5-formyl-C and their roles in epigenetics.

                    Comment

                    • krobison
                      Senior Member
                      • Nov 2007
                      • 734

                      #11
                      Oxford is probably a poor choice for sequencing targeted regions, given that most targeted sequencing is looking for small variations (such as SNPs) and Oxford looks out-of-the-box to not be well suited for this. Also, all of the existing capture schemes are designed around small fragments suitable for short read sequencers. It would seem that capture sequencing is playing to none of Oxford's strengths and against many of its likely weaknesses.

                      Comment

                      Latest Articles

                      Collapse

                      • SEQadmin2
                        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                        by SEQadmin2


                        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                        The systematic characterization of the human proteome has
                        ...
                        07-20-2026, 11:48 AM
                      • SEQadmin2
                        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                        by SEQadmin2



                        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                        ...
                        07-09-2026, 11:10 AM
                      • SEQadmin2
                        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                        by SEQadmin2



                        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                        07-08-2026, 05:17 AM

                      ad_right_rmr

                      Collapse

                      News

                      Collapse

                      Topics Statistics Last Post
                      Started by SEQadmin2, Yesterday, 12:17 PM
                      0 responses
                      14 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-23-2026, 11:41 AM
                      0 responses
                      15 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-20-2026, 11:10 AM
                      0 responses
                      23 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-13-2026, 10:26 AM
                      0 responses
                      37 views
                      0 reactions
                      Last Post SEQadmin2  
                      Working...